The international college of neuro-psychopharmacology (CINP) treatment guidelines for bipolar disorder in adults (CINP-BD-2017), Part 3: The clinical guidelines

International Journal of Neuropsychopharmacology

Volumn 20, Issue 2, 2017, Pages 180-195

  Fountoulakis, Konstantinos N ^a   Grunze, Heinz ^b   Vieta, Eduard ^c   Young, Allan ^d   Yatham, Lakshmi ^e   Blier, Pierre ^f   Kasper, Siegfried ^g   Moeller, Hans Jurgen ^h  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b PARACELSUS MEDICAL UNIVERSITY   (Austria)

^c UNIVERSITY OF BARCELONA   (Spain)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f UNIVERSITY OF OTTAWA   (Canada)

^g MEDICAL UNIVERSITY OF VIENNA   (Austria)

^h UNIVERSITY OF MUNICH   (Germany)

Author keywords

Anticonvulsants; Antidepressants; Antipsychotics; Bipolar depression; Bipolar disorder; Clinical trials; Evidence based guidelines; Lithium; Mania; Mood stabilizers; Treatment

Indexed keywords

ANTIDEPRESSANT AGENT; ORAL CONTRACEPTIVE AGENT; TRANQUILIZER; CARBAMAZEPINE; LITHIUM; VALPROIC ACID; NEUROLEPTIC AGENT;

ACUTE DISEASE; ADULT; AGITATION; BIPOLAR DEPRESSION; BIPOLAR DISORDER; BREAST FEEDING; HUMAN; HYPOMANIA; LONG TERM CARE; MAINTENANCE THERAPY; MONOTHERAPY; ORAL CONTRACEPTIVE USE; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PSYCHOSOMATIC DISORDER; REVIEW; TREATMENT DURATION; ARTICLE; EVIDENCE BASED PRACTICE; PSYCHOPHARMACOLOGY; TREATMENT OUTCOME; CLINICAL TRIAL (TOPIC); PROCEDURES; STANDARDS;

ADULT; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CLINICAL TRIALS AS TOPIC; GUIDELINES AS TOPIC; HUMANS; PSYCHOPHARMACOLOGY;

EID: 85018310257     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1093/ijnp/pyw109     Document Type: Review

References (104)

1. (1997) Expert consensus guidelines are released for the treatment of bipolar disorder. Consensus Development Conferences. Am Fam Physician 55:1447-1449.
2. (2008) International Consensus Group on the evidence-based pharmacologic treatment of bipolar I and II depression. J Clin Psychiatry 69:1632-1646.
3. AACAP (1997) AACAP official action. Practice parameters for the assessment and treatment of children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 36:138-157.
4. Adams J, Scott J. (2000) Predicting medication adherence in severe mental disorders. Acta Psychiatr Scand 101:119-124.
5. Allen MH, Currier GW, Hughes D.H., Reyes-Harde M, Docherty J.P. (2001) The Expert Consensus Guideline Series. Treatment of behavioral emergencies. Postgrad Med:1-88; quiz 89-90.
6. Altshuler LL, Hendrick V.C. (1996) Pregnancy and psychotropic medication: changes in blood levels. J Clin Psychopharmacol 16:78-80.
7. American Academy of Pediatrics Committee on Drugs (2001) Transfer of drugs and other chemicals into human milk. Pediatrics 108:776-789.
8. APA (1994) Practice guideline for the treatment of patients with bipolar disorder. Am J Psychiatry 151:1-36.
9. APA (1995) American Psychiatric Association releases treatment guideline for bipolar disease. Am Fam Physician 51:1605-1606.
10. APA (2002) Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 159:1-50.
11. Austin MP, Mitchell P.B. (1998) Use of psychotropic medications in breast-feeding women: acute and prophylactic treatment. Aust N Z J Psychiatry 32:778-784.
12. Barreira P, Duckworth K, Goff D., Flannery RB Jr (1999) Clinical practice guidelines: the Massachusetts experience in psychiatry. Harv Rev Psychiatry 7:230-232.
13. Bauer MS, Callahan AM, Jampala C, Petty F., Sajatovic M, Schaefer V, Wittlin B., Powell B.J. (1999) Clinical practice guidelines for bipolar disorder from the Department of Veterans Affairs. J Clin Psychiatry 60:9-21.
14. Beaulieu S, Saury S, Sareen J., Tremblay J, Schutz CG, McIntyre R.S., Schaffer A., Canadian Network for M, Anxiety Treatments Task F (2012) The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid substance use disorders. Ann Clin Psychiatry 24:38-55.
15. Bergman U, Rosa FW, Baum C, Wiholm B.E., Faich G.A. (1992) Effects of exposure to benzodiazepine during fetal life. Lancet 340:694-696.
16. Bhatia SC, Baldwin SA, Bhatia S.K. (1999) Electroconvulsive therapy during the third trimester of pregnancy. J ECT 15:270-274.
17. Bond DJ, Hadjipavlou G, Lam R.W., McIntyre RS, Beaulieu S, Schaffer A, Weiss M., Canadian Network for M, Anxiety Treatments Task F (2012) The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid attention-deficit/hyperactivity disorder. Ann Clin Psychiatry 24:23-37.
18. Bulut M, Bez Y, Kaya M.C., Copoglu US, Bulbul F, Savas H.A. (2013) Electroconvulsive therapy for mood disorders in pregnancy. J ECT 29:e19-20.
19. Burt VK, Rasgon N. (2004) Special considerations in treating bipolar disorder in women. Bipolar Disord 6:2-13.
20. Burt VK, Suri R, Altshuler L., Stowe Z, Hendrick VC, Muntean E. (2001) The use of psychotropic medications during breastfeeding. Am J Psychiatry 158:1001-1009.
21. Carvalho AF, Quevedo J, McIntyre R.S., Soeiro-de-Souza MG, Fountoulakis KN, Berk M, Hyphantis TN, Vieta E (2015) Treatment implications of predominant polarity and the polarity index: a comprehensive review. Int J Neuropsychopharmacol 18.
22. Cesta CE, Mansson M, Palm C., Lichtenstein P, Iliadou AN, Landen M. (2016) Polycystic ovary syndrome and psychiatric disorders: co-morbidity and heritability in a nationwide Swedish cohort. Psychoneuroendocrinology 73:196-203.
23. Chouinard G, Annable L, Turnier L., Holobow N, Szkrumelak N. (1993) A double-blind randomized clinical trial of rapid tranquilization with I.M. clonazepam and I.M. haloperidol in agitated psychotic patients with manic symptoms. Can J Psychiatr 38:S114-121.
24. Citrome L (2012) Inhaled loxapine for agitation revisited: focus on effect sizes from 2 Phase III randomised controlled trials in persons with schizophrenia or bipolar disorder. Int J Clin Pract 66:318-325.
25. Colom F, Vieta E, Martinez-Aran A, Reinares M., Benabarre A, Gasto C. (2000) Clinical factors associated with treatment noncompliance in euthymic bipolar patients. J Clin Psychiatry 61:549-555.
26. Dennehy EB (2000) Guidelines for treatment of bipolar disorder. Curr Psychiatry Rep 2:316-321.
27. Echevarria Moreno M., Martin Munoz J, Sanchez Valderrabanos J, Vazquez Gutierrez T (1998) Electroconvulsive therapy in the first trimester of pregnancy. J ECT 14:251-254.
28. Ernst CL, Goldberg J.F. (2002) The reproductive safety profile of mood stabilizers, atypical antipsychotics, and broad-spectrum psychotropics. J Clin Psychiatry 63:42-55.
29. Fountoulakis K (2015a) Neurocognitive functioning in bipolar disorder: a comprehensive review of recent data. In: Bipolar disorder: an evidence-based guide to manic depression (Fountoulakis K, ed), pp 109-162. Berlin Heidelberg: SpringerVerlag.
30. Fountoulakis K (2015b) Comorbidity. In: Bipolar disorder: an evidence-based guide to manic depression (Fountoulakis K, ed), pp 225-340. Berlin Heidelberg: Springer-Verlag.
31. Fountoulakis K (2015c) Biological therapies. In: Bipolar disorder: an evidence-based guide to manic depression (Fountoulakis K, ed), pp 461-625. Berlin Heidelberg: Springer-Verlag.
32. Fountoulakis K (2015d) Psychosocial treatment and interventions. In: Bipolar disorder: an evidence-based guide to manic depression (Fountoulakis K, ed), pp 627-642. Berlin Heidelberg: Springer-Verlag.
33. Fountoulakis K (2015e) Treatment guidelines. In: Bipolar disorder: an evidence-based guide to manic depression (Fountoulakis K, ed), pp 643-658. Berlin Heidelberg: Springer-Verlag.
34. Fountoulakis K (2015f) Clinical description. In: Bipolar disorder: an evidence-based guide to manic depression (Fountoulakis K, ed), pp 27-80. Berlin Heidelberg: Springer-Verlag.
35. Fountoulakis KN, Vieta E, Sanchez-Moreno J, Kaprinis S.G., Goikolea JM, Kaprinis G.S. (2005) Treatment guidelines for bipolar disorder: a critical review. J Affect Disord 86:1-10.
36. Frances A, Docherty J, Kahn D. (1996) The expert consensus guideline series: treatment of bipolar disorder. J Clin Psychiatry 57:1-88.
37. Frye MA, Ha K, Kanba S., Kato T, McElroy SL, Ozerdem A, Vazquez G., Vieta E. (2011) International consensus group on depression prevention in bipolar disorder. J Clin Psychiatry 72:1295-1310.
38. Gahr M, Klink S, Schonfeldt-Lecuona C (2013) Electroconvulsive therapy in pregnancy revisited. Psychosomat Med 75:894.
39. Garriga M et al. (2016) Assessment and management of agitation in psychiatry: Expert consensus. World J Biol Psychiatry 17:86-128.
40. Gilbert DA, Altshuler KZ, Rago W.V., Shon SP, Crismon ML, Toprac MG, Rush A.J. (1998) Texas Medication Algorithm Project: definitions, rationale, and methods to develop medication algorithms. J Clin Psychiatry 59:345-351.
41. Goldberg JF (2000) Treatment guidelines: current and future management of bipolar disorder. J Clin Psychiatry 61:12-18.
42. Goodwin G, Bourgeois M, Conti L. (1997) Treatment of bipolar depressive mood disorders: algorithms for pharmacotherapy. Int J Psychiatry Clin Pract 1:S9-S12.
43. Goodwin GM (2003) Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 17:149-173; discussion 147.
44. Goodwin GM (2009) Evidence-based guidelines for treating bipolar disorder: revised second edition - recommendations from the British Association for Psychopharmacology. J Psychopharmacol 23:346-388.
45. Goodwin GM, Haddad PM, Ferrier I.N., Aronson JK, Barnes T, Cipriani A, Coghill D.R., Fazel S., Geddes JR, Grunze H, Holmes EA, Howes O, Hudson S., Hunt N, Jones I, Macmillan I.C., McAllister-Williams H, Miklowitz DR, Morriss R, Munafo M., Paton C, Saharkian, BJ, Saunders K, Sinclair J, Taylor D, Vieta E, Young AH (2016). Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology. J Psychopharmacol 30:495-553
46. Grande I, Berk M, Birmaher B., Vieta E. (2016) Bipolar disorder. Lancet 387:1561-1572.
47. Grunze H, Kasper S, Goodwin G., Bowden C, Baldwin D, Licht R., Vieta E, Moller H.J. (2002) World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: treatment of bipolar depression. World J Biol Psychiatry 3:115-124.
48. Grunze H, Kasper S, Goodwin G., Bowden C, Baldwin D, Licht R.W., Vieta E., Moller H.J. (2003) The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, Part II: treatment of mania. World J Biol Psychiatry 4:5-13.
49. Grunze H, Kasper S, Goodwin G., Bowden C, Moller H.J. (2004) The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment. World J Biol Psychiatry 5:120-135.
50. Grunze H, Vieta E, Goodwin G.M., Bowden C., Licht RW, Moller HJ, Kasper S. (2009) The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania. World J Biol Psychiatry 10:85-116.
51. Grunze H, Vieta E, Goodwin G.M., Bowden C., Licht RW, Moller HJ, Kasper S, Disorders WTFOTGFB (2010) The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2010 on the treatment of acute bipolar depression. World J Biol Psychiatry 11:81-109.
52. Grunze H, Vieta E, Goodwin G.M., Bowden C., Licht RW, Moller HJ, Kasper S, Disorders WTFoTGfB (2013) The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder. World J Biol Psychiatry 14:154-219.
53. Hirschfeld R (2005) Guideline watch for the practice guideline for the treatment of patients with bipolar disorder. Arlington, VA: American Psychiatric Association.
54. Hirschfeld RM, Allen MH, McEvoy J.P., Keck PE, Jr., Russell JM (1999) Safety and tolerability of oral loading divalproex sodium in acutely manic bipolar patients. J Clin Psychiatry 60:815-818.
55. Jobson K (1997) International Psychopharmacology Algorithm Project: algorithms in psychopharmacology. Int J Psychiatry Clin Pract 1:S3-S8.
56. Jon DI, Bahk WM, Yoon B.H., Shin YC, Cho HS, Lee E, Ha K., Kim W, Chung SK, Seo J.S., Min K.J. (2009) Revised Korean medication algorithm for bipolar disorder. World J Biol Psychiatry 10:846-855.
57. Kasar M, Saatcioglu O, Kutlar T. (2007) Electroconvulsive therapy use in pregnancy. J ECT 23:183-184.
58. Kusumakar V, Yatham L, Parikh S. (1997) Bipolar disorder: a summary of clinical issues and treatment options. Halifax, Nova Scotia: CANMAT Monograph.
59. Kwentus J, Riesenberg RA, Marandi M, Manning R.A., Allen MH, Fishman RS, Spyker DA, Kehne J.H., Cassella J.V. (2012) Rapid acute treatment of agitation in patients with bipolar I disorder: a multicenter, randomized, placebo-controlled clinical trial with inhaled loxapine. Bipolar Disord 14:31-40.
60. Leiknes KA, Cooke MJ, Jarosch-von Schweder L, Harboe I, Hoie B (2015) Electroconvulsive therapy during pregnancy: a systematic review of case studies. Arch Women Mental Health 18:1-39.
61. Licht RW, Vestergaard P, Kessing L.V., Larsen JK, Thomsen P.H. (2003) Psychopharmacological treatment with lithium and antiepileptic drugs: suggested guidelines from the Danish Psychiatric Association and the Child and Adolescent Psychiatric Association in Denmark. Acta Psychiatr Scand 108 Suppl 419:1-22.
62. Lim PZ, Tunis SL, Edell W.S., Jensik SE, Tohen M. (2001) Medication prescribing patterns for patients with bipolar I disorder in hospital settings: adherence to published practice guidelines. Bipolar Disord 3:165-173.
63. Malhi GS, Bassett D, Boyce P., Bryant R, Fitzgerald PB, Fritz K, Hopwood M., Lyndon B, Mulder R, Murray G., Porter R, Singh A.B. (2015) Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Aust N Z J Psychiatry 49:1087-1206.
64. McClellan J, Werry J. (1997) Practice parameters for the assessment and treatment of children and adolescents with bipolar disorder. American Academy of Child and Adolescent Psychiatry. J Am Acad Child Adolesc Psychiatry 36:157S-176S.
65. McElroy SL, Keck PE, Stanton S.P., Tugrul KC, Bennett JA, Strakowski S.M. (1996) A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania. J Clin Psychiatry 57:142-146.
66. McIntyre RS, Alsuwaidan M, Goldstein B.I., Taylor VH, Schaffer A, Beaulieu S, Kemp D.E., Canadian Network for M, Anxiety Treatments Task F (2012) The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid metabolic disorders. Ann Clin Psychiatry 24:69-81.
67. Meehan K, Zhang F, David S., Tohen M, Janicak P, Small J., Koch M, Rizk R, Walker D., Tran P, Breier A. (2001) A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania. J Clin Psychopharmacol 21:389-397.
68. Miller LJ (1994) Use of electroconvulsive therapy during pregnancy. Hosp Community Psychiatry 45:444-450.
69. Mohammad O, Osser D.N. (2014) The psychopharmacology algorithm project at the Harvard South Shore Program: an algorithm for acute mania. Harv Rev Psychiatry 22:274-294.
70. Montgomery DB (2001) ECNP Consensus Meeting March 2000 Nice: guidelines for investigating efficacy in bipolar disorder. European College of Neuropsychopharmacology. Eur Neuropsychopharmacol 11:79-88.
71. Muller-Oerlinghausen B., Muser-Causemann B, Volk J. (1992) Suicides and parasuicides in a high-risk patient group on and off lithium long-term medication. J Affect Disord 25:261-269.
72. National Collaborating Centre for Mental Health (2006) Bipolar disorder. The management of bipolar disorder in adults, children and adolescents, in primary and secondary care. CG38 NICE Guideline.
73. Ng F, Mammen OK, Wilting I, Sachs G.S., Ferrier IN, Cassidy F, Beaulieu S, Yatham L.N., Berk M. (2009) The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments. Bipolar Disord 11:559-595.
74. NICE (2014) Bipolar disorder: the assessment and management of bipolar disorder in adults, children and young people in primary and secondary care
75. Nice FJ, Luo A.C. (2012) Medications and breast-feeding: current concepts. J Am Pharm Assoc 52:86-94.
76. Nolen W, Kupka R, Schulte P., Knoppert-van der Klein E, Honig A, Reichart C (2008) Richtlijn bipolaire stoornissen. 2nd ed. Utrecht: De Tijdstrom Uitgerverij BV.
77. O'Dowd A (2006) NICE issues new guidance to improve the treatment of bipolar disorder. BMJ 333:220.
78. Ostacher MJ, Tandon R, Suppes T. (2015) Florida best practice psychotherapeutic medication guidelines for adults with bipolar disorder: a novel, practical, patient-centered guide for clinicians. J Clin Psychiatry 77:920-927.
79. Pacchiarotti I et al. (2013) The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry 170:1249-1262.
80. Richards DS (2007) Is electroconvulsive therapy in pregnancy safe? Ob Gyn 110:451-452.
81. Rosenbluth M, Macqueen G, McIntyre R.S., Beaulieu S., Schaffer A, Canadian Network for M, Anxiety Treatments Task F (2012) The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid personality disorders. Ann Clin Psychiatry 24:56-68.
82. Rush AJ, Crismon ML, Kashner T.M., Toprac MG, Carmody TJ, Trivedi MH, Suppes T, Miller A.L., Biggs MM, Shores-Wilson K, Witte BP, Shon S.P., Rago WV, Altshuler K.Z. (2003) Texas Medication Algorithm Project, phase 3 (TMAP-3): rationale and study design. J Clin Psychiatry 64:357-369.
83. Rush AJ, Rago WV, Crismon M.L., Toprac MG, Shon SP, Suppes T, Miller A.L., Trivedi MH, Swann AC, Biggs MM, Shores-Wilson K, Kashner T.M., Pigott T., Chiles JA, Gilbert DA, Altshuler K.Z. (1999) Medication treatment for the severely and persistently mentally ill: the Texas Medication Algorithm Project. J Clin Psychiatry 60:284-291.
84. Sachs GS, Printz DJ, Kahn D.A., Carpenter D., Docherty J.P. (2000) The expert consensus guideline series: medication treatment of bipolar disorder 2000. Postgrad Med Spec No:1-104.
85. Sajatovic M, Davies M, Hrouda D.R. (2004) Enhancement of treatment adherence among patients with bipolar disorder. Psychiatr Serv 55:264-269.
86. Schaffer A, McIntosh D, Goldstein B.I., Rector NA, McIntyre RS, Beaulieu S, Swinson R., Yatham LN, Canadian Network for M, Anxiety Treatments Task F (2012) The CANMAT task force recommendations for the management of patients with mood disorders and comorbid anxiety disorders. Ann Clin Psychiatry 24:6-22.
87. Scott J, Pope M. (2002) Self-reported adherence to treatment with mood stabilizers, plasma levels, and psychiatric hospitalization. Am J Psychiatry 159:1927-1929.
88. Spodniakova B, Halmo M, Nosalova P. (2014) Electroconvulsive therapy in pregnancy: review. J Ob Gyn 1-4.
89. Suppes T, Calabrese J, Mitchell P., Pazzaglia P, Potter W, Zarin D. (1995) Algorithms for the treatment of bipolar manic-depressive illness. Psychopharmacol Bull 31:469-474.
90. Suppes T, Swann AC, Dennehy E.B., Habermacher ED, Mason M, Crismon ML, Toprac M.G., Rush AJ, Shon SP, Altshuler K.Z. (2001) Texas Medication Algorithm Project: development and feasibility testing of a treatment algorithm for patients with bipolar disorder. J Clin Psychiatry 62:439-447.
91. Suppes T, Dennehy EB, Swann A.C., Bowden CL, Calabrese JR, Hirschfeld RM, Keck P.E., Jr., Sachs GS, Crismon ML, Toprac MG, Shon SP (2002) Report of the Texas Consensus Conference Panel on medication treatment of bipolar disorder 2000. J Clin Psychiatry 63:288-299.
92. Suppes T, Rush AJ, Dennehy E.B., Crismon ML, Kashner TM, Toprac MG, Carmody T.J., Brown ES, Biggs MM, Shores-Wilson K, Witte BP, Trivedi M.H., Miller AL, Altshuler KZ, Shon S.P. (2003) Texas Medication Algorithm Project, phase 3 (TMAP-3): clinical results for patients with a history of mania. J Clin Psychiatry 64:370-382.
93. van Gent E.M., Zwart F.M. (1991) Psychoeducation of partners of bipolar-manic patients. J Affect Disord 21:15-18.
94. Vieta E, Valenti M. (2013) Mixed states in DSM-5: implications for clinical care, education, and research. J Affect Disord 148:28-36.
95. Wagner EH (1998) Chronic disease management: what will it take to improve care for chronic illness? Effect Clin Pract 1:2-4.
96. Walker R, Swartz C.M. (1994) Electroconvulsive therapy during high-risk pregnancy. Gen Hosp Psychiatry 16:348-353.
97. Woo YS, Lee JG, Jeong J.H., Kim MD, Sohn I, Shim SH, Jon D.I., Seo JS, Shin YC, Min KJ, Yoon B.H., Bahk W.M. (2015) Korean Medication Algorithm Project for Bipolar Disorder: third revision. Neuropsych Dis Treat 11:493-506.
98. Yacobi S, Ornoy A. (2008) Is lithium a real teratogen? What can we conclude from the prospective versus retrospective studies? A review. Isr J Psychiatry Relat Sci 45:95-106.
99. Yatham LN, Kennedy SH, O'Donovan C, Parikh SV, MacQueen G, McIntyre R.S., Sharma V., Beaulieu S, Guidelines Group C (2006) Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007. Bipolar Disord 8:721-739.
100. Yatham LN, Kennedy SH, O'Donovan C, Parikh S, MacQueen G., McIntyre R, Sharma V, Silverstone P., Alda M, Baruch P, Beaulieu S., Daigneault A, Milev R, Young L.T., Ravindran A., Schaffer A, Connolly M, Gorman CP, Canadian Network for M, Anxiety T (2005) Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies. Bipolar Disord 7:5-69.
101. Yatham LN, Kennedy SH, Schaffer A, Parikh S.V., Beaulieu S., O'Donovan C, MacQueen G, McIntyre R.S., Sharma V., Ravindran A, Young LT, Young A.H., Alda M., Milev R, Vieta E, Calabrese J.R., Berk M., Ha K, Kapczinski F. (2009) Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord 11:225-255.
102. Yatham LN, Kennedy SH, Parikh S.V., Schaffer A., Beaulieu S, Alda M, O'Donovan C, Macqueen G, McIntyre R.S., Sharma V., Ravindran A, Young LT, Milev R, Bond D.J., Frey BN, Goldstein B.I. (2013a) The evolution of CANMAT Bipolar Disorder Guidelines: past, present, and future. Bipolar Disord 15:58-60.
103. Yatham LN et al. (2013b) Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord 15:1-44.
104. Yonkers KA, Wisner KL, Stowe Z, Leibenluft E., Cohen L, Miller L, Manber R., Viguera A, Suppes T, Altshuler L. (2004) Management of bipolar disorder during pregnancy and the postpartum period. Am J Psychiatry 161:608-620.